Gaston Capital
1104 Spruce Street Suite 100, Belmont, NC, 28012, United States
Overview
Gaston Capital Partners, LLC, a private equity firm in Gastonia, North Carolina. He has more than thirty-five years experience managing investment portfolios and working with small businesses. Gaston Capital Partners has investments in specialty pharmaceuticals, cardio-assist, hip, knee, shoulder and total disc replacement devices, print rolls and industrial turbines.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Financial Services
Investment portfolio
- Intezyne Technologies
Led · Series A · Oct 2017
Intezyne Technologies is a clinical-stage biopharmaceutical company developing novel anti-cancer therapies, including IT-139 (a Cancer Resistance Pathway inhibitor) and IT-141 (a topoisomerase I inhibitor). IT-139 is being developed for pancreatic, gastric and BRAF-mutated cancers, while IT-141 targets colorectal and breast cancers. IT-139 has previously received Orphan Drug Designation for pancreatic cancer; preclinical data and a completed Phase 1 safety study support potential benefit in its target indications. The company cites poor survival rates in pancreatic and advanced gastric cancers to underscore the unmet need its programs address. Intezyne plans to advance IT-139 and IT-141 through Phase 1/2 trials and to prioritize which indications to pursue based on compelling data and development rationale. The company recently closed a financing that strengthens its balance sheet as it progresses development and seeks strategic partnerships.
Team
No current team members are available.